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Abstract:

Investigating the Effects of Trans-Spinal Direct Current Stimulation on The Expression
of NKCC1 In Mice

By
Pasindu Weliwaththage

Advisor: Dr. Zaghloul Ahmed
Trans-spinal direct current stimulation (tsDCS) is a non-invasive powerful tool
demonstrated to positively affect behavior and motor function. tsDCS is a
neuromodulatory technique capable of altering spinal and cortical excitability and even
regain motor function after complete motor paralysis (Cortes et at, 2017). tsDCS causes
immediate and long-term effects in spinal excitability (Ahmed, 2011, 2013; Ahmed and
Wieraszko, 2012; Cogiamanian et al., 2011, 2012). Studies have been conducted on both
healthy and injured subjects. The ultimate goal is to ameliorate the devastating effects of
Spinal Cord Injury. Though researchers have been successful in improving motor
function, the molecular basis of the recovery still remains unknown. Our objective for
this study was to investigate the effect of tsDCS on transporter protein NKCC1 for both
healthy and injured animals.
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Introduction:
Na+-K+-2Cl− (NKCC1) and K+-Cl- (KCC2) are neuron specific co-transporters
that play a vital role in neuronal Cl- homeostasis. NKCC1 increases intracellular Clconcentration, and result in GABA mediated excitatory cellular responses. KCC2
decreases intracellular Cl- concentration, resulting in hyperpolarization (inhibitory)
response in GABA. It is already known, that functional imbalance of NKCC1 and KCC2
contributes to induction and maintenance of neuropathic pain after spinal cord injury
(Hasbargen et al; 2010). We will be analyzing one of the Sodium-Potassium-Chloride
Transporter Protein (NKCC1).
Research has shown that the effects of tDCS induce polarity dependent changes in
the membrane excitability, with membrane depolarization caused by anodal stimulation
and hyperpolarization caused by cathodal stimulation (Liebetanz et al., 2002). Thus, in
this study, we hypothesized tsDCS stimulation will increase the expression of NKCC1
gene in both spinal cord injured and non-injured mice.
In this study, we will be examining the effects of tsDCS on the expression of
NKCC1 gene in spinal code injured and non-injured mice. We will be answering whether
the difference in anodal or cathodal tsDCS stimulation has any effects on NKCC1
expression in spinal cord injured and non-injured mice? Our study groups include injured
and stimulated animals, only injured animals and only stimulated animals. Stimulation
paradigm includes single session and repeatedly stimulated animals. These findings will
help us understand the pathways involved in regeneration, repair, and recovery and will
lay the foundation of future therapeutics for spinal cord injury.
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Materials and Methods
Animals: a total of 16 Adult CD1 mice (41-52 days old) of both sexes were used
for this study. Animals were housed under a 12-hour light/dark cycles with access to food
and water. The protocols used in this study were approved by the Institutional Animal
Care and Use Committee of the College of Staten Island.
Surgical Procedure: mice were anesthetized using ketamine/xylazine (90/10
mg/kg, i.p.) before surgically removing the skin covering the dorsolumbar spinal column.
tsDCS spinal electrode, connected to a DC stimulator was placed on the fascia of the
spine covering the vertebral level T11 to L6. Electrode stimulation: in the non-injured
animal study, three animals were stimulated using cathodal tsDCS, three by anodal
tsDCS and two animals were used as shams, which were prepared in the same way but
not stimulated. The animals were stimulated with 1.0mA current for 90 minutes. In the
injured animal study three animals were stimulated using cathodal tsDCS, three by
anodal tsDCS and two animals were used as controls. These animals were stimulated
repeatedly for seven consecutive days, with a current strength of 1.0mA for 20 minutes.
Tissue preparation: the animals in both studies were transcardially perfused with
PBS, followed by 4% paraformaldehyde (PFA). The region of the spinal code (segment
L1-L3) underneath the tsDCS electrode was surgically removed and transferred to 4%
PFA fixative overnight. The tissues were then transferred to 30% sucrose solution for
another 24hr. For analysis, target regions from the spinal cord were mounted for
cryosectioning using dry ice, optimum cutting temperature (OCT) compound (TissueTek; Sakura), and Cryomold Intermediate (Tissue-Tek; Sakura). The tissues were
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sectioned transversely (30-µM). The sections were transferred to wells in a culture plate
containing 0.1 M PBS.
For NKCC1 immunolabeling and imaging, the spinal code sections were washed
three times with 0.1 M PBS buffer (10min/wash). The sections were then treated with
10% donkey serum-0.1%Triton X-100/0.1 M PBS blocking solution. After 30 minutes,
the sections were rinsed with 0.1 M PBS three times (10min/wash) and incubated with
primary NKCC1 mouse monoclonal antibody (NKCC1, 1:400; sc-514774; Santa Cruz
Biotechnology, Santa Cruz, CA) overnight at 4°C. The following day the sections were
washed three times with 0.1 M PBS (10min/wash) and then incubated with AlexaFluor
488 secondary antibody (goat anti-mouse, 1:500; sc-362257; Santa Cruz Biotechnology,
Santa Cruz, CA) for 60 minutes. After another three washes with 0.1 M PBS (10
min/wash) the sections were mounted using Vectashield mounting medium (Vector
Laboratories). The sections were then imaged using laser confocal microscopy and
ImageJ software was used to analyze expression of NKCC1.
Results:
The animals in the non-injured study were stimulated for 90 min, the group
consisted of three animals that received cathodal tsDCS (c-tsDCS), three animals that
received anodal tsDCS (a-tsDCS) and two animals that were used as shams. The spinal
code tissue under the electrode was resected from these animals. X 10 magnification
images (Fig. 1) of the spinal code were transferred to ImageJ. To analyze expression of
NKCC1, the mean fluorescence intensity was measured near the ventral region of the
spinal code. The data are presented as mean ± SE. As shown in Table 1, the anodal
tsDCS group showed a mean intensity value of 17.4 ± 2.9, the cathodal tsDCS group
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showed a value of 21.0 ± 2.9 and the sham showed a value of 19.3 ± 3.2.
The animals in the injured study were stimulated repeatedly for five consecutive
days, with a current strength of 1.0mA for 20 min/day. The spinal code tissue under the
electrode was resected from the three animals that received cathodal tsDCS (c-tsDCS),
three animals that received anodal tsDCS (a-tsDCS) and the two animals that were used
as controls. X 10 magnification images of the spinal code were transferred to ImageJ. To
analyze expression of NKCC1, the mean fluorescence intensity was measured near the
ventral region of the spinal code. As shown in Table 2, the anodal tsDCS group showed a
mean intensity value of 16.7 ± 0.7, the cathodal tsDCS group showed a value of 19.7 ±
1.1 and the control showed a value of 17.3 ± 3.7.
Discussion:
Trans-spinal direct current stimulation (tsDCS), is a proven powerful tool
demonstrated to positively affect behavior and motor function. In this study, we
examined the effects of tsDCS on NKCC1 expression in spinal cord injured and noninjured mice. Our study groups included injured and stimulated animals, only injured
animals and only stimulated animals. Stimulation paradigm includes single session and
repeatedly stimulated animals. The data collected supports the original hypothesis that
tsDCS would result in a higher expression of NKCC1 gene in both spinal cord injured
and non-injured mice. In the uninjured animals and acute stimulation, the cathodal tsDCS
group showed a higher NKCC1 expression, than the anodal tsDCS group or the sham. In
the injured animals with repeated consecutive seven days stimulation, similar results were
observed with the cathodal tsDCS group showing a higher NKCC1 expression, compared
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to the anodal tsDCS group or the control.
Although the mechanisms underlying the tsDCS-induced changes in expression of
NKCC1 remains unknown; from our results which showed a higher NKCC1 expression
in cathodal tsDCS compared to anodal tsDCS, we can speculate that the mechanisms
underlying cathodal and anodal tsDCS could differ in that they may affect different
circuits, pathways, and neurotransmitters in a system. Therefore, cathodal current
stimulation might act on one target system (e.g. NKCC1) whereas anodal stimulation acts
on another. The method and novel findings presented in the current study has the
potential to facilitate future research in therapeutics for spinal cord injury.
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Figure 1: NKCC1 immunostaining of
spinal cord sections of uninjured
mice. Representative sections from
anodal, cathodal and sham tsDCS (1.0
mA/90 min).

Table 1: Mean fluorescence intensity of NKCC1 in uninjured animals
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Table 2: Mean fluorescence intensity of NKCC1 in injured animals.

Control

Figure 2: NKCC1 immunostaining
of spinal cord sections of injured
mice. Representative sections
from seven days consecutively
repeated anodal, cathodal and
control tsDCS (1.0 mA/ 20
min/day).
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Figure 3: electrodes

Figure 4: DC stimulator.

Figure 5: Animals with tsDCS electrodes connected to DC
stimulators.
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